| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 8e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |